MERCK's RECOMBIVAX HB DNA-DERIVED HEPATITIS VACCINE APPROVED JUNE 23 AFTER FIVE-MONTH REVIEW; MERCK WILL BEGIN MARKETING IN JANUARY

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".